M

Medicofarma Biotech SA
WSE:MDB

Watchlist Manager
Medicofarma Biotech SA
WSE:MDB
Watchlist
Price: 0.377 PLN -2.08% Market Closed
Market Cap: 25.6m PLN
Have any thoughts about
Medicofarma Biotech SA?
Write Note

Medicofarma Biotech SA
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medicofarma Biotech SA
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
M
Medicofarma Biotech SA
WSE:MDB
Gross Profit
zł491.4k
CAGR 3-Years
-14%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Gross Profit
-zł204k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Gross Profit
zł40.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
13%
S
Selvita SA
WSE:SLV
Gross Profit
zł258.9m
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Medicofarma Biotech SA
Glance View

Market Cap
25.6m PLN
Industry
Life Sciences Tools & Services

Medicofarma Biotech SA is a biotechnology company, which focuses on the innovative medicine, medicinal products, and biotechnology products. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2008-11-27. The company is engaged in works on drugs, medical devices and biotechnological products. It's research and development works are carried out in laboratories in Lublin and Poznan.

MDB Intrinsic Value
0.096 PLN
Overvaluation 75%
Intrinsic Value
Price
M

See Also

What is Medicofarma Biotech SA's Gross Profit?
Gross Profit
491.4k PLN

Based on the financial report for Dec 31, 2023, Medicofarma Biotech SA's Gross Profit amounts to 491.4k PLN.

What is Medicofarma Biotech SA's Gross Profit growth rate?
Gross Profit CAGR 5Y
-18%

Over the last year, the Gross Profit growth was -54%. The average annual Gross Profit growth rates for Medicofarma Biotech SA have been -14% over the past three years , -18% over the past five years .

Back to Top